Why Your Injection Site Matters

GLP-1 receptor agonists are designed for subcutaneous delivery, meaning they need to be injected into the fat layer just beneath the skin. This allows the medication to absorb slowly and steadily into the bloodstream, which is essential for maintaining consistent therapeutic levels throughout the week.
Injecting too shallow (into the skin) causes irritation and inconsistent absorption. Injecting too deep (into muscle) can cause the medication to absorb too quickly, leading to a spike in side effects and a shorter duration of action.
The right site and technique ensure that your medication works the way it was designed to: steadily and predictably.





































































































